Ischemia Care
Blood test for cause of stroke and transient ischemic attacks (TIA).
- Stage Product In Development
- Industry Biotechnology
- Location Cincinnati, OH, USA
- Currency USD
- Founded January 2009
- Employees 5
- Website iscdx.com
Company Summary
Ischemia Care (ISC) is a pioneer in the field of stroke; engaged in diagnostic development, laboratory testing, precision medicine, and bioinformatics to improve patient outcomes and reduce healthcare costs. The goal of ISC is to become the standard of care blood test for stratifying all stroke and TIA patients, as well as, unlock the mechanisms for stroke leading to revolutionary new t point of care diagnostics.
Team
-
CEO | Founder
Extensive early stage company start up and investing experience (including exits and IPO). Founded life science company that built distribution into over 600 research and medical centers.
Former professor and chair at Miami University.
Passionate about creating better outcomes for stroke patients.
-
Dr. Donald Harrison, MDBoard member and Medical Advisor
Founder and director of numerous life sciences companies. Managing Director at Charter Life Sciences. Past President of AHA. Former Chief of Cardiology,Stanford. http://www.charterls.com/t-harrison.html
Advisors
-
Alan Fershtman, KMK, Cincinnati, OHLawyerUnconfirmedSeveral local audit, tax and consulting firmsAccountantUnconfirmed
Previous Investors
-
Queen City Angels, management and private individualsUnconfirmedCleveland Clinic, through the Global Cardio Vascular Innovation CenterUnconfirmedOhio Third Frontier, Innovation Ohio Loan FundUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.